| Celeste Lynn Marcoux, MS, SLP-CF | |
|
19411 Mckay Dr Ste 300, Humble, TX 77338-5713 | |
| (281) 446-2680 | |
| (281) 446-2689 |
| Full Name | Celeste Lynn Marcoux |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 19411 Mckay Dr Ste 300, Humble, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083388268 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 118599 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Celeste Lynn Marcoux, MS, SLP-CF 19411 Mckay Dr Ste 300, Humble, TX 77338-5713 Ph: (719) 440-3350 | Celeste Lynn Marcoux, MS, SLP-CF 19411 Mckay Dr Ste 300, Humble, TX 77338-5713 Ph: (281) 446-2680 |
News Archive
The mesoporous material Upsalite is shown to inhibit growth of bacteria associated with acne and hospital acquired infections.
A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation therapy.
Some three billion base pairs make up the human genome-the floor plan of life. In 2003, the Human Genome Project announced the successful decryption of this code, a tour de force that continues to supply a stream of insights relevant to human health and disease.
Spectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, today announced new clinical data presented in an oral presentation for ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use at the 17th Congress of the European Hematology Association (EHA).
Frustrated by the slow pace of new drug development for a condition that causes pediatric brain tumors, a neurologist at Washington University School of Medicine in St. Louis decided to try to fine-tune the animal models used to test new drugs.
› Verified 2 days ago
Mrs. Laura Nicole Achivida, M.A.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18700 W. Lake Houston Pkwy, Suite 102, Humble, TX 77346 Phone: 713-338-9768 Fax: 713-366-4359 | |
Gabrielle Callens, M.S., SLP INTERN Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19411 Mckay Dr Ste 300, Humble, TX 77338 Phone: 281-446-2680 | |
Christy Taylor, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5510 Atascocita Rd, 150, Humble, TX 77346 Phone: 281-852-6211 Fax: 281-852-3295 | |
Chelsi Yates, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 323 E Main St, Humble, TX 77338 Phone: 773-466-2486 | |
Luz Maria Elias, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19411 Mckay Dr Ste 300, Humble, TX 77338 Phone: 281-446-2680 Fax: 281-446-2689 | |
Brittney Kay Moore, MS, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19411 Mckay Dr Ste 300, Humble, TX 77338 Phone: 281-446-2680 | |
Sarah Frances Zahirniak, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19100 W Lake Houston Pkwy Ste 104, Humble, TX 77346 Phone: 281-812-9519 |